Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kexue Luo

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Public Health|May 2, 2022
A Transfer Learning Method for Detecting Alzheimer's Disease Based on Speech and Natural Language ProcessingNing Liu, Kexue Luo, Zhenming Yuan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|July 11, 2019
Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver diseaseKexue Luo, Jie Bian, Qinxian Wang, et al.
Drug Design, Development and Therapy|January 20, 2022
Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling PathwayHongchun Li, Kexue Luo, Zhuying Yang, et al.
Oncotargets and Therapy|April 21, 2020
Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial-Mesenchymal Transition in Pancreatic Cancer CellsHongchun Li, Miao Chen, Zhuying Yang, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Public Health|May 2, 2022
A Transfer Learning Method for Detecting Alzheimer's Disease Based on Speech and Natural Language ProcessingNing Liu, Kexue Luo, Zhenming Yuan, et al.
The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|July 11, 2019
Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver diseaseKexue Luo, Jie Bian, Qinxian Wang, et al.
Drug Design, Development and Therapy|January 20, 2022
Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling PathwayHongchun Li, Kexue Luo, Zhuying Yang, et al.
Oncotargets and Therapy|April 21, 2020
Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial-Mesenchymal Transition in Pancreatic Cancer CellsHongchun Li, Miao Chen, Zhuying Yang, et al.
Pageof 1